All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit Know GvHD.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi, Therakos and Incyte. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View GvHD content recommended for you
ECP in routine GvHD care: A practical guide
Do you know... Which of the following statements is NOT a contraindication to ECP?
Extracorporeal photopheresis (ECP) is an immunomodulatory, leukapheresis-based procedure widely used as a second-line or later treatment option for steroid-refractory acute and chronic graft-versus-host disease (GvHD), although it is not yet approved for this indication.1,2 ECP can be performed using either an open or closed system.
Our educational mini-module focuses on ECP performed using a closed system and provides an overview of the procedural workflow along with key practical considerations for use in routine care.
This educational resource is independently supported by Therakos. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
Your opinion matters
What do you consider to be the main potential advantage of mesenchymal stromal cells in the treatment of acute GvHD?
